Loss of HER2 Positivity After Anti-Her2 Chemotherapy in HER2-positive Gastric Cancer Patients: Results of the GASTric Cancer HER2 Reassessment Study 3 (GASTHER3)
Gastric Cancer - Germany
doi 10.1007/s10120-018-0891-1
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2018
Authors
Publisher
Springer Science and Business Media LLC